Clearwave Capital’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Clearwave Capital's LLY Position: Q3 2026 in Review
Clearwave Capital increased its Eli Lilly (LLY) stake by 9.4% in Q3 2026, buying an estimated $73.2K and bringing the position to 725 shares worth $839K. The position accounts for 0.44% of the portfolio, ranked #49.
Clearwave Capital first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. 4,625 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Clearwave Capital held 725 shares of Eli Lilly worth $839K as of Q3 2026.
- Clearwave Capital bought 62 Eli Lilly shares in Q3 2026, an estimated $73.2K.
- Eli Lilly made up 0.44% of Clearwave Capital's portfolio in Q3 2026, its #49 holding.
- Clearwave Capital first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
- 4,625 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Clearwave Capital's 13F filing for Q3 2026, filed 27 Oct 2026.